CS Paper Radar

Unified Multiparadigm Fusion Intelligence for Rare Disease Diagnosis

Jian Yang, Peiling Liu, Songda Li, Yu Cao, Yuqing Feng, Lan Yu, Jiarong Pan, Jing Ye, Xinwen Huang, Chaochun Zou, Xudong Lu, Huilong Duan, Haomin Li

cs.AI cs.LG ·submitted 2026-10-16 03:52 UTC · v1

Abstract

Rare diseases (RDs) affect an estimated 300 million people globally, leaving patients to navigate a protracted diagnostic odyssey constrained by clinical scarcity and fragmented medical knowledge. Artificial intelligence (AI) has progressively advanced RD diagnostics, from symbolic methods and deep learning to large language model (LLM)-based systems. However, each paradigm carries structural limitations: symbolic methods are bounded by knowledge completeness, neural models sacrifice interpretability, and LLM-based systems are vulnerable to evaluation biases like data leakage. In this study, we introduce FusionRare, a unified multiparadigm fusion framework integrating knowledge-driven symbolic reasoning, deep-learning pattern recognition, case-based patient retrieval, and LLM-based heuristic inference via statistical meta-aggregation and knowledge-enhanced agentic reflection. Evaluated on 2,528 strictly isolated clinical cases, FusionRare achieves state-of-the-art RD prioritization, attaining a macro-averaged Recall @1 of 51% for phenotype-only diagnosis and 79% for phenotype-genotype joint analysis. These results represent decisive advantages over the advanced agentic system DeepRare, frontier LLMs including GPT 5.5, and specialized tools like PhenoBrain and LIRICAL under stringent anti-leakage protocols. A randomized, crossover clinician-AI validation demonstrated that FusionRare elevates the true diagnostic rank in 45% of decisions, improves physician confidence in 62%, and reduces time to diagnosis by 21%. These findings indicate that reconciling these orthogonal AI paradigms significantly enhances diagnostic capabilities, bridging the gap between computational benchmarks and actionable clinical reliability. More broadly, this work provides a replicable framework for deploying trustworthy diagnostic AI across complex, high-stakes, and underserved medical domains.

Comment
26 pages, 5 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Sparse Multi-Stage Expert-Agent Routing for Complex Clinical Reasoning

cs.CV ·2026-08-22 ·Sike Xiang, Shuang Chen, Qian sun, Jia Cheng, Yusi Wei +1 more
similarity 0.69
Abstract

Complex clinical reasoning requires models to update diagnostic hypotheses as new evidence emerges and to coordinate different medical specialities under limited consultation resources. Existing LLM-based clinical reasoning systems typically perform single-pass prediction or rely on fixed multi-agent workflows, making expert participation either static or unnecessarily exhaustive. We propose Sparse Multi-Stage Expert-Agent Routing, a language-based clinical reasoning framework that models diagnosis as a stage-wise routing process. Given progressively available clinical evidence derived from multiple modalities, the framework maintains an evolving case state and adaptively activates a sparse set of medical expert agents, supported by expert-specific memory across stages. To evaluate free-text diagnostic conclusions beyond surface similarity, we further introduce ClinFEScore, a fact-aware semantic evaluation protocol for clinical reasoning outputs. On reconstructed multi-stage cases from MAC and AgentClinic-NEJM, our framework reduces the average number of activated experts from 17.0 to 3.0 whilst maintaining strong fact-level diagnostic quality. On 200 real-world hospital MDT cases, ClinFEScore correlates strongly with clinician judgements (Spearman's $ρ=0.81$; Pearson's $r=0.87$), whilst our method achieves 91.5\% clinician-verified diagnostic accuracy with approximately five expert-agent/LLM calls per case. These results support sparse stage-wise coordination as an efficient and clinically relevant approach to LLM-based clinical reasoning.

0.38

SUP-MIMIC: A Multi-Task Clinical Diagnosis Benchmark for Evaluating LLMs' Robustness to Contradictory Evidence

cs.CL cs.AI ·2026-08-30 ·Yi Yu, Bo Wang, Chong Feng, Ge Shi, Xia Liu +2 more
benchmark similarity 0.68
Abstract · 18 pages, 13 figures, 3 table

Current evaluations of large language models (LLMs) primarily focus on factual knowledge retrieval, overlooking the fundamental challenge of navigating the complex, non-bijective mappings between clinical indicators and diagnoses. Existing benchmarks fail to assess whether large language models truly possess the reasoning capability required for diagnostic ambiguity scenarios, where identical clinical presentations may correspond to different etiologies, and diagnostic convergence scenarios, where heterogeneous symptoms ultimately indicate the same disease. To address this issue, we propose SUP-MIMIC, a multi-task framework utilizing MIMIC-IV-v3.1 that comprises Basic Assessment (BA), Diagnostic Divergence Task (DDT), and Diagnostic Convergence Task (DCT). Specifically, DDT is designed to evaluate the model's "one-to-many" disambiguation capability among phenotypically similar cases, while DCT assesses the model's ability to identify "many-to-one" diagnostic patterns across different pathophysiological pathways. Comprehensive evaluation of state-of-the-art LLMs reveals substantial performance degradation on DDT and DCT compared to baseline tasks, exposing a systemic reliance on statistical shortcuts over genuine causal reasoning. Our findings further highlight a conservative bias toward "healthy" predictions, implying non-trivial risks for missed diagnoses in realistic medical settings. This work establishes a rigorous methodology for quantifying clinical reasoning robustness and provides a roadmap for enhancing the safety of language models in clinical medicine.

0.20

EMR: Self-Evolving Medical Multi-Agent System via Experience Mining and Reuse

cs.CL cs.AI ·2026-09-14 ·Dongsheng Shi, Yue Li, Xin Yi, Linlin Wang
similarity 0.68
Abstract

Large language model (LLM) driven multi-agent systems have shown promise in complex clinical reasoning, yet existing approaches rely on static strategies and lack persistent clinical memory, preventing self-evolving from prior diagnostic successes and failures. We present EMR, a self-evolving medical multi-agent system via Experience Mining and Reuse. EMR introduces a hierarchical clinical experience library that organizes accumulated knowledge into three levels: clinical principles, diagnostic patterns, and representative cases. During inference, EMR emulates multidisciplinary consultation: a planner agent coordinates domain-specific department agents for specialized reasoning, while a summary agent synthesizes their analyses into a final decision. Critically, EMR automatically extracts correct diagnostic insights and failure-related warnings from multi-agent reasoning trajectories, incrementally updating the experience library to guide future cases. Experiments on medical reasoning benchmarks demonstrate that EMR consistently outperforms state-of-the-art medical multi-agent baselines. Further analysis reveals that the hierarchical experience enables cross-specialty generalization and transfer across diverse LLM backbones, offering a scalable and in

0.26

Learning to Fuse LLMs with Ontology Rankers for Rare-Disease Diagnosis

cs.CL ·2026-09-02 ·Zhaoyang Jiang, Zhizhong Fu, Yunsoo Kim, Zicheng Li, Xuanqi Peng +3 more
benchmark similarity 0.68
Abstract

Ontology rankers remain useful for rare-disease diagnosis because each candidate can be traced to matched patient phenotypes. Large language models (LLMs) can generate differential diagnoses from the same patient description, but their predictions lack an equally clear evidence trail. Rather than asking which system should replace the other, we ask whether an LLM can improve the ranker without giving up its evidence. Our behavior-based fusion model examines the two ranked lists, their agreement, and the ontology support behind each candidate, and learns how much to rely on each system for the individual case. Before comparison, we remove a documented test-set leakage pathway caused by benchmark cases and ontology annotations being derived from the same publications. Across eight open LLMs, fusion improves Phenomizer Recall@1 by 7.86 percentage points on Phenopacket Store and 20.18 points on RAMEDIS. When paired with DeepSeek-V4-Flash through an API, a fusion model trained only on the other LLMs improves Recall@1 from 0.1657 to 0.2176, a 5.19-point gain, without retraining. For 90.8% of correct fused diagnoses, the disease retains candidate-level ontology evidence that can be inspected. These results show that LLMs can strengthen an established diagnostic tool without discarding the structured evidence that makes it useful.

0.16

RareDx: Controlled Knowledge Integration and Graph-Grounded Policy Optimization for Rare-Disease Diagnosis

cs.AI ·2026-09-28 ·Bo Zhang, Yuchen Wang, Dongbai Li, Matthew Yu Heng Wong, Qingkai Zeng +4 more
similarity 0.67
Abstract · 21 pages, 8 figures

Rare-disease diagnosis is a long-tail reasoning problem: phenotypes are incomplete, individual disorders are sparsely documented, and relevant evidence is distributed across ontologies, gene annotations, and biomedical text. Language models consequently favor common conditions, miss rare candidates, or produce plausible but invalid names. We introduce RareDx, which couples controlled evidence use with knowledge-graph-grounded policy optimization. RareDx-Harness normalizes heterogeneous records into one ranked-diagnosis task and compares direct inference, static retrieval, adaptive tools, and structured phenotype-gene-disease reasoning over a shared knowledge layer. The training pipeline combines Top-10 post-training with RareDx-KGPO, our knowledge-graph-grounded policy optimization method. Its reward projects predictions into a canonical disease graph and integrates curated graded relevance, ontology proximity, biomedical similarity, and phenotype consistency. Vocabulary and output-budget constraints prevent dense partial credit from rewarding fabricated or overlong differentials. Across eight benchmarks, the complete RareDx system centered on Qwen3.5-9B reaches 38.34 macro Hit@10, 1.60 points above GPT-5.5 under the archived protocol; a disjoint validation-selection audit retains a 6.80-point routing gain over Direct on held-out cases. The 27B system reaches 23.53/36.56/40.76 at Hit@1/5/10. Controlled ablations show that retrieval is not uniformly helpful and that controlled routing is central to the gain. These results indicate that structured medical knowledge can turn a compact model into a competitive diagnostic ranker across heterogeneous long-tail settings in clinical practice.

0.17

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.66
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25

Glyph: An Interpretability Engine for AI-Driven Scientific Discovery in Clinical Data

cs.AI ·2026-11-06 ·Robbie Holland, Ashwin Kumar, Mateus A. Esmeraldo, David Le, Andrea Fisher +17 more
code/data similarity 0.65
Abstract

Automated scientific discovery has the potential to advance understanding of disease mechanisms and accelerate identification of early disease markers. Manual data annotation is infeasible at population scale, motivating methods that automatically extract pre-defined phenotypes in multimodal and unstructured clinical data. Such pre-defined feature sets determine and limit which associations these approaches can discover. This limitation extends to agentic AI systems that use these tools to query population-scale data. In contrast, foundation models (FMs) trained on large volumes of clinical data can perform tasks beyond their training objectives. This suggests their latent embeddings may represent novel or unexplored features that could yield insights into disease mechanisms, yet such latent features remain difficult to interpret. To address this challenge, we introduce Glyph, an automated multistage framework that extracts features from multimodal and unstructured clinical data using FMs and sparse autoencoders, interprets them as coded clinical concepts, and evaluates their value for clinical scientific discovery. We applied Glyph to abdominal CT volumes, CT radiology reports and laboratory measurements from 41,628 patients across different institutions. We identified 397 predictive concepts supported by 4,463 Bonferroni-significant associations. Moreover, a majority of discovered associations were automatically reproducible in held-out cohorts across different sites. Glyph concepts provided complementary associations to literature-derived markers, leading to gains in predictive power. We envision that interpretability can extend beyond a mechanistic understanding of neural networks to connecting implicitly learned features with clinical knowledge and establishing their significance for patient outcomes. We release Glyph at https://github.com/StanfordMIMI/Glyph.

0.40

Beyond Federated Learning: Decentralized Agentic Systems for Self-Evolving Clinical Intelligence

cs.AI ·2026-10-26 ·Haoyuan Li, Mathias Funk, Aaqib Saeed
position similarity 0.65
Abstract

Clinical expertise is inherently distributed: it resides not in any single dataset or institution but in the accumulated reasoning experiences of thousands of clinicians navigating diverse patient populations, resource constraints, and evolving treatment protocols. Yet current approaches to scaling medical AI, from centralized large language models to federated learning, remain anchored to a data-centric paradigm that treats knowledge as static parameters to be aggregated. In this Perspective, we argue for a fundamental shift from data aggregation to experience aggregation. We propose Decentralized Agentic Systems (DAS), a framework in which distributed AI agents operating across healthcare institutions synthesize collective clinical intelligence by sharing abstracted reasoning trajectories rather than raw data or model parameters. Unlike federated learning, which averages numerical gradients across homogeneous model architectures, DAS exchanges structured records of clinical reasoning, specifically the sequence of observations, hypotheses, tool invocations, and outcome feedback that constitute diagnostic experience. We examine the architectural principles, deployment considerations, governance requirements, and critical open challenges of this framework, laying the groundwork for a collaborative medical AI ecosystem where distributed expertise autonomously adapts to the complexities of longitudinal patient care.

0.09